Schonfeld Strategic Advisors’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-109,310
| Closed | -$328K | – | 2012 |
|
2023
Q3 | $328K | Buy |
+109,310
| New | +$328K | ﹤0.01% | 1184 |
|
2023
Q1 | – | Sell |
-75,300
| Closed | -$263K | – | 2454 |
|
2022
Q4 | $263K | Sell |
75,300
-75,200
| -50% | -$262K | ﹤0.01% | 1832 |
|
2022
Q3 | $5.57M | Buy |
+150,500
| New | +$5.57M | 0.05% | 492 |
|
2022
Q1 | – | Sell |
-54,800
| Closed | -$1.24M | – | 2662 |
|
2021
Q4 | $1.24M | Sell |
54,800
-58,138
| -51% | -$1.31M | 0.01% | 777 |
|
2021
Q3 | $2.96M | Buy |
112,938
+55,177
| +96% | +$1.45M | 0.03% | 529 |
|
2021
Q2 | $1.85M | Buy |
57,761
+3,260
| +6% | +$104K | 0.02% | 706 |
|
2021
Q1 | $1.92M | Buy |
+54,501
| New | +$1.92M | 0.02% | 644 |
|